Program

Plenaries in English *Plenaries in English will be live-streamed for online participants.

Plenary Speakers (Provisional)

Plenary Lecture

Unraveling the Mechanisms of Sleep(tentative)
Thursday, May 20, 13:10-14:55
Room 1: "Main Hall" ICC Kyoto 1F

Masashi Yanagisawa
International Institute for Integrative Sleep Medicine, University of Tsukuba, Japan

Semi-Plenary Lecture 01

Integrated approaches towards therapies for ALS(tentative)
Thursday, May 20, 15:15-16:00
Room 4: "Room A" ICC Kyoto 2F

Lucie Bruijn
Translational Medicine, EMEA at AveXis, Inc., USA

Semi-Plenary Lecture 02

Parkinson's disease -its Past, Present and Future(tentative)
Friday, May 21, 13:40-14:25
Room 4: "Room A" ICC Kyoto 2F

Werner Poewe
Department of Neurology, Medical University of Innsbruck, Austria

Semi-Plenary Lecture 03

APOE4 Leads to Blood-Brain Barrier Dysfunction Predicting Cognitive Decline(tentative)
Friday, May 21, 13:40-14:25
Room 05: "Room B-1" ICC Kyoto 2F

Berislav V. Zlokovic
Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, USA

Special Lecture

Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two ways(tentative)
Friday, May 21, 15:40-16:25
Room 4: "Room A" ICC Kyoto 2F

Steven M. Greenberg
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, USA)

Symposia in English (Provisional)

*All Symposia in English will be live-streamed for online participants.
*This program is as of November 2020 and subject to change.

Wednesday, May 19 AM
  • Novel therapeutic approach for neurological disorders using stem cell biology and genetic modification
  • Selective vulnerability of alpha-synuclein-related neurodegeneration -beyond proteinopathy and propagation-
Wednesday, May 19 PM
  • Coevolution of multimodal neuroimaging and biomarkers
  • RBD as a harbinger of synucleinopathy: update
  • New Frontiers in the Treatment of Epilepsy 2020
Thursday, May 20 AM
  • Will new migraine medications save migraine patients?
  • Interdisciplinary research between dementia and epilepsy
Thursday, May 20 PM
  • Cutting-edge advances in NMOSD and MOG-related disorders
  • Frontiers of neuroscience and medicine accelerated by big data and AI
  • Reassessment APOE4 in Alzheimer's disease
  • New diagnostic and therapy strategies for PSP/CBD
  • Novel molecular target drugs for MG: How should we use them?
Friday, May 21 AM
  • Innovative management can bring bright future for Parkinson's disease
  • Neurologic Specialty Board in the World
  • Novel therapeutic strategies against ischemic stroke from the perspective of neuro-glial-vascular unit
Friday, May 21 PM
  • Structure and propagation of aggregated proteins
  • Increasing importance of autonomic neuroscience in multiple system atrophy
  • Disassemble "CIDP"! Reclassification of "CIDP" based on molecular autoimmune mechanism
Saturday, May 22 AM
  • Dyskinesia in Parkinson's Disease: Filling the Bedside-to-Bench Gap
  • Motor neuron disease: revisiting the roles of RNA binding proteins and RNA metabolism in neurodegeneration
  • How to treat obstructive sleep apnea syndrome in older adults? -Missing treatment option for dementia-
Saturday, May 22 PM
  • Strategy toward regenerative medicine in neurological disorders using stem cells - the current situation and issues